Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

37.79
+0.97002.63%
Volume:292.85K
Turnover:10.97M
Market Cap:5.08B
PE:-10.85
High:37.90
Open:36.95
Low:36.70
Close:36.82
52wk High:49.70
52wk Low:8.77
Shares:134.37M
Float Shares:129.77M
Volume Ratio:0.39
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4823
EPS(LYR):-2.0600
ROE:-64.09%
ROA:-20.64%
PB:5.53
PE(LYR):-18.34

Loading ...

OverviewCompanyNewsFilings

China's Lepu Biopharma H1 Revenue Rises 12.1% on Higher Drug Sales

Reuters
·
6 hours ago

Stifel Nicolaus Reaffirms Their Buy Rating on Definium Therapeutics (DFTX)

TIPRANKS
·
12 hours ago

Definium Therapeutics is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Yesterday

U.S. Research Roundup-Eli Lilly, McDonald's, Welltower

Reuters
·
Yesterday

UK's ImmuPharma Interim Net Loss Widens on Derivative Finance Loss

Reuters
·
Yesterday

UK's ValiRx Half-Year Loss Narrows, Cash Position Improves

Reuters
·
Yesterday

Kestra Medical Technologies Q1 Revenue Beats Estimates, Raises FY Revenue Outlook

Reuters
·
Yesterday

Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs

Reuters
·
Yesterday

Definium Therapeutics price target raised to $91 from $75 at BofA

TIPRANKS
·
Yesterday

FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace

Reuters
·
Yesterday

Analysts’ Top Healthcare Picks: Corbus Pharmaceuticals (CRBP), Definium Therapeutics (DFTX)

TIPRANKS
·
Yesterday

Top Midday Stories: No OpenAI IPO in 2026, Altman Reportedly Says; Nvidia, Palantir Said to Restrict AI Usage Over Customer Data Fears

MT Newswires Live
·
Sep 14

First Marijuana, Then Peptides. Why Psychedelics are Wall Street's Next Big Trip.

Dow Jones
·
Sep 14

Definium Therapeutics Inc : Leerink Partners Raises Target Price to $70 from $52

THOMSON REUTERS
·
Sep 14

Definium Therapeutics Price Target Maintained with a $66.00/Share by Needham

Dow Jones
·
Sep 14

Definium Therapeutics Shares Gain After Reporting Positive Results in Anxiety Study

Dow Jones
·
Sep 14

Definium Therapeutics Shares Jump 20% Premarket After Co's Lsd-Based Drug Lowers Anxiety in Second Successful Late-Stage Study

THOMSON REUTERS
·
Sep 14

S&P 500 Futures Decline in Premarket Trading; Definium Therapeutics, Primo Brands Lead

Dow Jones
·
Sep 14

Definium Therapeutics: DT120 Odt 100 Mcg Generally Well Tolerated with Consistent Safety Profile; no New Safety Signals

THOMSON REUTERS
·
Sep 14

Definium Therapeutics: DT120 Pre-Nda Meeting Scheduled for Q4; Nda Filing Expected H1 2027

THOMSON REUTERS
·
Sep 14
More